Related Experiment Video
Updated: Jul 13, 2026

Venous Thrombosis Assay in a Mouse Model of Cancer
Published on: January 5, 2024
Association between cytomegalovirus infection and venous thromboembolism
Zvi G Fridlender1, Mogher Khamaisi, Eran Leitersdorf
1Division of Medicine, Hadassah--Hebrew University Medical Center, Jerusalem, Israel. fridlender@hadassah.org.il
Insights
Cytomegalovirus (CMV) infection may increase the risk of blood clots (thrombosis) in both immunocompromised and immunocompetent individuals. Clinicians should consider CMV infection as a potential risk factor for thrombophilia.
Area of Science:
- Infectious Diseases
- Hematology
- Clinical Medicine
Background:
- Cytomegalovirus (CMV) infection is a known concern in immunocompromised patients.
- Sporadic reports suggest a link between CMV and thrombotic events in immunocompetent individuals.
Observation:
- This study reports on nine adult patients (1 immunocompromised, 8 immunocompetent) who experienced venous thromboembolic events during acute CMV infection.
- None of the patients had a prior history of thromboembolic events.
Findings:
- Seven patients presented with vein thromboses.
- Five patients had identifiable thrombophilia, including elevated anti-cardiolipin IgM antibodies in one case.
Implications:
- CMV infection should be recognized as a potential risk factor for thrombophilia.
- A high index of suspicion for thrombotic events is warranted in patients with CMV infection.
- Consideration of prophylactic anticoagulation may be necessary.
Abstract:
It has been suggested that cytomegalovirus (CMV) infection may be associated with thrombosis in immunocompromised patients. In addition, an association between CMV infection and thrombotic events in immunocompetent hosts has been sporadically reported. We report on 1 immunocompromised and 8 immunocompetent adults who were admitted to a tertiary medical center and experienced a venous thromboembolic event during CMV infection. None reported previous thromboembolic events. All patients were diagnosed as suffering from acute CMV infection. Seven of the patients had vein thromboses. Significant additional thrombophilia was identified in 5 patients; 1 had 15.3 U/mL anti-cardiolipin IgM antibodies (elevated >7), 2 others were not evaluated for genetic procoagulant tendency. The exact nature of the procoagulant effect of CMV has not yet been clarified. Even though these mechanistic studies are incomplete, we suggest that from the clinical perspective, the presence of CMV infection should be considered a possible risk factor for thrombophilia, justifying a high index of suspicion for possible thrombotic events and subsequent decisions regarding prophylactic anticoagulation.
More Related Videos
Related Concept Videos
Cytomegalovirus Disease
Venous Thrombosis I: Introduction
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis III: Interprofessional Care
Cryptococcal Meningitis
Venous Thrombosis IV: Nursing Management

